Cover Image

Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies

Saved in:

Bibliographic Details
Main Authors:	Zakir Khan (Author), Yusuf Karatas (Author), Ahmet Akici (Author), Maria Auxiliadora Parreiras Martins (Author), Nafees Ahmad (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
by: Yoshihiro Noguchi, et al.
Published: (2023)

Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
by: Wen Zou, et al.
Published: (2024)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
by: Zakir Khan, et al.
Published: (2020)

Pharmacovigilance and incidence of adverse drug reactions in hospitalized pediatric patients: a mini systematic review
by: Zakir Khan, et al.
Published: (2020)

Observational Pharmacoepidemiology in the Drug Safety and Effectiveness Evaluation
by: José Cabrita, et al.
Published: (2017)

Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs
by: Antonia Agustí, et al.
Published: (2023)

A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime
by: Cheng Jiang, et al.
Published: (2024)

Pharmacoepidemiology and pharmacovigilance in pregnancy: experience of the regional service of clinical pharmacology
by: E V Eliseeva, et al.
Published: (2013)

New Insights into the Future of Pharmacoepidemiology and Drug Safety
Published: (2021)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
by: Łukasz Dobrek
Published: (2022)

Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital
by: Zakir Khan, et al.
Published: (2021)

Corrigendum: Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital
by: Zakir Khan, et al.
Published: (2021)

The American Program in Pharmacovigilance (Am2P): a new accredited online training program in pharmacovigilance and pharmacoepidemiology
by: Veronique Kugener, et al.
Published: (2024)

Post-marketing safety evaluation of lurbinectedin: a pharmacovigilance analysis based on the FAERS database
by: Zhao Li, et al.
Published: (2024)

Pharmacovigilance: the evolution of drug safety monitoring
by: Muhammad Akhtar Abbas Khan, et al.
Published: (2024)

Editorial: Women in pharmacoepidemiology: 2021
by: Luciane Cruz Lopes, et al.
Published: (2023)

Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post‐marketing safety
by: Cheng Jiang, et al.
Published: (2024)

Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database
by: Wensheng Liu, et al.
Published: (2023)

Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on the FDA adverse event reporting system
by: Tingting Jiang, et al.
Published: (2022)

Drug Safety Crises Management in Pharmacovigilance
by: Gloria Shalviri, et al.
Published: (2018)

The role of pharmacoepidemiological studies in the market withdrawal of carisoprodol (Somadril®) in Europe
by: Jørgen G. Bramness, et al.

PHARMACOEPIDEMIOLOGY IN THE ASSORTMENT POLICY-PRODUCER OF DRUGS
by: V. Y. Krasnov
Published: (2015)

Pharmacoepidemiological study of the safety of drug use in children by analyzing the Russian database of spontaneous reports
by: A. R. Titova, et al.
Published: (2018)

Self-Medication in Pakistan: Urgent Need for Medical Education and Policy Implementation
by: Junaid Khan, et al.
Published: (2024)

Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
by: Dan Zhao, et al.
Published: (2024)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
by: Augusto Garcia-Agundez, et al.
Published: (2022)

PHARMACOEPIDEMIOLOGICAL STUDIES OF ADVERSE REACTIONS OF DEVELOPED DRUGS
by: E. J. Kolesnikova
Published: (2022)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019)

Assessment of the association between drug disposal practices and drug use and storage behaviors
by: Ahmet Akici, et al.
Published: (2018)

The crucial role of pharmacovigilance in managing infectious diseases in lower and middle-income countries
by: Zakir Khan, et al.
Published: (2024)

The pharmacoepidemiology of potential drug-drug interactions in patients with psychiatric disorders
by: O. O. Kirilochev, et al.
Published: (2020)

Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study
by: V. V. Strizheletsky, et al.
Published: (2022)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021)

Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 2-Comparison of the Performance of Artificial Intelligence and Traditional Pharmacoepidemiological Techniques
by: Maurizio Sessa, et al.
Published: (2021)

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS
by: E. V. Shubnikova, et al.
Published: (2018)

Editorial: Pharmacoepidemiology in Diabetes Mellitus and its Complications: Focus on Response to Medications
by: Soroush Mohammadi Jouabadi, et al.
Published: (2022)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
by: Augusto Garcia-Agundez, et al.
Published: (2023)

Federation Pharmacological Safety in Pregnancy: Modern Knowledge, Practice and Pharmacoepidemiological Approaches to the Studying and Recognizing of Drugs with Teratogenic Risk
by: Konstantin A. Lutsevich, et al.
Published: (2019)

The Norwegian Society for Pharmacoepidemiology
by: Angela Lupattelli, et al.
Published: (2021)

Data resource profile: Norwegian Databases for Drug Utilization and Pharmacoepidemiology
by: Hilchen Thode Sommerschild, et al.
Published: (2021)